Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A

被引:2
|
作者
Huang, Yongpeng [1 ]
Tang, Hui [1 ]
Meng, Xiangyan [1 ]
Zhao, Zitong [1 ]
Liu, Yanli [1 ]
Liu, Dongxin [1 ]
Chen, Bo [1 ]
Zou, Zhiyun [1 ]
机构
[1] State Key Lab NBC Protect Civilian, Beijing 102205, Peoples R China
关键词
dry powder inhalations; large hollow particles; hydroxypropyl methylcellulose; spray drying; pulmonary delivery; cyclosporine A; SOLID DISPERSION; DRY POWDERS; NANOPOROUS MICROPARTICLES; L-LEUCINE; FORMULATION; INHALATION; AEROSOLIZATION; IMPACT; PYRAZINAMIDE; EXCIPIENTS;
D O I
10.3390/pharmaceutics15092204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to prepare large hollow particles (LHPs) by spray drying for pulmonary delivery of cyclosporine A (CsA), using L-Leucine (LEU) and hydroxypropyl methylcellulose (HPMC) as excipients and ammonium bicarbonate (AB) as a porogen. The prepared LHPs were spherical particles composed of both CsA and LEU on the surface and HPMC on the inner layer. The formulation of CsA-LEU-0.8HPMC-AB as typical LHPs showed excellent in vitro aerodynamic performance with a minimum mass median aerodynamic diameter (MMAD) of 1.15 & mu;m. The solubility of CsA-LEU-0.8HPMC-AB was about 5.5-fold higher than that of raw CsA, and the dissolution of CsA-LEU-0.8HPMC-AB suggested that the drug was released within 1 h. The cell viability of the A549 cell line showed that CsA-LEU-0.8HPMC-AB was safe for delivering CsA to the lungs. In addition, inhalation administration of CsA-LEU-0.8HPMC-AB with the Cmax and AUC0-& INFIN; increasing by about 2-fold and 2.8-fold compared with the oral administration of Neoral & REG; could achieve therapeutic drug concentrations with lower systemic exposure and significantly improve the in vivo bioavailability of CsA. From these findings, the LHPs, with the advantage of avoiding alveolar macrophage clearance, could be a viable choice for delivering CsA by inhalation administration relative to oral administration.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Optimization of Hollow Aliphatic Polyurethane Particles Used as a Drug Delivery System
    Trandafirescu, Cristina
    Ledeti, Ionut
    Coricovac, Dorina E.
    Soica, Codruta M.
    Pinzaru, Iulia
    Dehelean, Cristina A.
    Iacob, Radu Emil
    Borcan, Florin
    MATERIALE PLASTICE, 2016, 53 (02) : 205 - 210
  • [32] Production of Ultrafine Sumatriptan Succinate Particles for Pulmonary Delivery
    Yang, Zong-Yang
    Le, Yuan
    Hu, Ting-Ting
    Shen, Zhigang
    Chen, Jian-Feng
    Yun, Jimmy
    PHARMACEUTICAL RESEARCH, 2008, 25 (09) : 2012 - 2018
  • [33] Development of Oral Drug Delivery System With Cyclosporine in Experimental Colitis
    Fukata, Norimasa
    Uchida, Kazushige
    Kusuda, Takeo
    Koyabu, Masanori
    Fukui, Toshiro
    Matsushita, Mitsunobu
    Nishio, Akiyoshi
    Nakase, Hiroshi
    Chiba, Tsutomu
    Tabata, Yasuhiko
    Okazaki, Kazuichi
    GASTROENTEROLOGY, 2010, 138 (05) : S413 - S414
  • [34] Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A
    Hermans, Kris
    Van den Plas, Dave
    Kerimova, Sabina
    Carleer, Robert
    Adriaensens, Peter
    Weyenberg, Wim
    Ludwig, Annick
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 472 (1-2) : 10 - 19
  • [35] Development of Novel Hollow Zein Nanoparticles for Delivery of Nutraceuticals
    Hu, Siqi
    Fernandez, Maria-Luz
    Luo, Yangchao
    FASEB JOURNAL, 2016, 30
  • [36] γ-Cyclodextrin metal-organic frameworks as the promising carrier for pulmonary delivery of cyclosporine A
    Huang, Yongpeng
    Tang, Hui
    Meng, Xiangyan
    Liu, Dongxin
    Liu, Yanli
    Chen, Bo
    Zou, Zhiyun
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 171
  • [37] Spray-dried raloxifene submicron particles for pulmonary delivery: Development and in vivo pharmacokinetic evaluation in rats
    Fontana, Marcia Camponogara
    Laureano, Joao Victor
    Forgearini, Betielli
    dos Santos, Juliana
    Pohlmann, Adriana Raffin
    Guterres, Silvia Staniscuaski
    de Araujo, Bibiana Verlindo
    Ruver Beck, Ruy Carlos
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 585
  • [38] Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application
    Yang, Likai
    Luo, Jing
    Shi, Sanjun
    Zhang, Qiang
    Sun, Xun
    Zhang, Zhirong
    Gong, Tao
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 451 (1-2) : 104 - 111
  • [39] Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system
    Yang, Ting-Ting
    Wen, Bao-Fang
    Liu, Kang
    Qin, Meng
    Gao, Yuan-Yuan
    Ding, De-Jun
    Li, Wen-Tong
    Zhang, Yun-Xiang
    Zhang, Wei-Fen
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 552 - 564
  • [40] Lymphatic delivery of 99mTc-labeled dextran acetate particles including cyclosporine A
    Kim, Jin
    Chung, Kyong-Hwan
    Lee, Chang-Moon
    Seo, Young-Soon
    Song, Ho-Chun
    Lee, Ki-Young
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2008, 18 (09) : 1599 - 1605